Acesso livre
Acesso livre

Destaques

Surto de hepatite em crianças: explicação sobre o adenovírus tipo 41, o possível culpado.

2 Mai, 2022 | 14:03h

Hepatitis outbreak in children: explainer on adenovirus type 41, the possible culprit – The Conversation

Conteúdos relacionados:

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing – UK Health Security Agency

Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization

WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT

CDC Alerts Providers to Hepatitis Cases of Unknown Origin – Centers for Disease Control and Prevention

Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology – Centers for Disease Control and Prevention

Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch

Increase in hepatitis (liver inflammation) cases in children under investigation – UK Health Security Agency

U.S., U.K. investigating unusual cases of hepatitis in young children – STAT

Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland – World Health Organization

Increase in acute hepatitis of unknown origin among children – United Kingdom – European Centre for Disease Prevention and Control

Mysterious liver illness seen in kids in US, Europe – Associated Press


Estudo randomizado | Vacina BCG não é efetiva em reduzir o absenteísmo de trabalhadores da atenção à saúde na pandemia de COVID-19.

2 Mai, 2022 | 14:01h

BCG vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial – Clinical Microbiology and Infection

 

Comentário no Twitter

 


OMS revela a chocante extensão da propaganda de fórmulas lácteas.

2 Mai, 2022 | 14:00h

Comunicado de imprensa: WHO reveals shocking extent of exploitative formula milk marketing – World Health Organization

Relatório: Scope and impact of digital marketing strategies for promoting breastmilk substitutes – World Health Organization

Conteúdo relacionado: More than half of parents and pregnant women exposed to aggressive formula milk marketing – WHO, UNICEF – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

 


M-A | Taxas de ataque secundário domiciliar de SARS-CoV-2 por variantes e status vacinal.

2 Mai, 2022 | 13:58h

Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis – JAMA Network Open

 

Comentário no Twitter

 


Série Lancet | Melhoria na saúde e no desenvolvimento da criança e do adolescente.

2 Mai, 2022 | 13:57h

Página principal: Optimising Child and Adolescent Health and Development – The Lancet (necessário cadastro gratuito para todos os artigos)

Health and development from preconception to 20 years of age and human capital

Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs

What can work and how? An overview of evidence-based interventions and delivery strategies to support health and human development from before conception to 20 years

Improving health and social systems for all children in LMICs: structural innovations to deliver high-quality services

Optimising child and adolescent health and development in the post-pandemic world

Opportunities in crisis for optimising child health and development


Análise | Uso de linguagem que desencoraja os pacientes.

29 Abr, 2022 | 15:17h

Presenting complaint: use of language that disempowers patients – The BMJ

Comunicado de imprensa: Language that belittles or blames patients is overdue for change – British Medical Journal


Covid-19: qual é a evidência para o uso do antiviral Paxlovid?

29 Abr, 2022 | 15:16h

Covid-19: What is the evidence for the antiviral Paxlovid? – The BMJ

Conteúdos relacionados:

Yes, Relapses After Paxlovid Happen — Now What? – HIV and ID Observations

WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator – World Health Organization

A living WHO guideline on drugs for covid-19 – The BMJ

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 – New England Journal of Medicine

Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions – Annals of Internal Medicine

The COVID-19 Treatment Guidelines Panel’s Statement on Potential Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications – NIH COVID-19 Treatment Guidelines Panel


Análise Rasch | Desenvolvimento e validação do questionário de impacto dos sintomas para Covid longa (symptom burden questionnaire for long covid – SBQ-LC).

29 Abr, 2022 | 15:15h

Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis – The BMJ

 

Comentário no Twitter

 


Estudo observacional | Impacto das vacinas contra Covid-19 na saúde pública dos EUA.

29 Abr, 2022 | 15:13h

Public health impact of covid-19 vaccines in the US: observational study – The BMJ

Editorial: The benefits of large scale covid-19 vaccination – The BMJ

 

Comentário no Twitter (fio – clique para saber mais)

 


Especialistas temem que os EUA padronizem o reforço anual de vacinas contra Covid sem dados suficientes.

29 Abr, 2022 | 15:11h

Experts fear U.S. may default to annual Covid boosters without sufficient data – STAT

 

Comentário no Twitter

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.